The growing interest in successful weight management has led to considerable exploration into groundbreaking treatments. Lately , Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor agonist , has shown positive results in medical trials, suggesting potential for substantial weight reduction . Conseque